Can probiotics alter the microbiome in breast cancer? new study investigates
NCT ID NCT04362826
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a probiotic called BIOHM can change the community of bacteria and fungi (the microbiome) in the breast and gut of people with breast cancer. Researchers will measure certain biomarkers in 100 participants to see if the probiotic has an effect. The goal is to better understand how microorganisms relate to breast cancer, which could lead to new prevention or treatment strategies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
probiotic (BIOHM)
What this could lead to
If successful, this could reveal how probiotics affect the microbiome in breast cancer, potentially pointing toward new ways to prevent, diagnose, or treat the disease.
What could go wrong
This is an early-stage study focused on measuring biological changes, not on curing or treating cancer directly. The probiotic may have no significant effect on the microbiome or cancer outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center
RECRUITINGCleveland, Ohio, 44122, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact